TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34793832

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Phakic controls
Number of subjects: 1195
Study: 35008112

Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Hot snare polypectomy (HSP)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: CSP and HSP
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: CSP
Number of subjects: 425
Study: 33464336

Group type: EXPERIMENTAL
Intervention: Discontinuation of ACEIs or ARBs (n=334)
Number of subjects: 659

Group type: COMPARATOR
Intervention: Continuation of ACEIs or ARBs (n=325)
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Discontinuation of ACEIs or ARBs
Number of subjects: 659

Group type: COMPARATOR
Intervention: Continuation of ACEIs or ARBs
Number of subjects: 659
Study: 32423936

Group type: EXPERIMENTAL
Intervention: Safe Step exercise programme with additional monthly educational videos about healthy ageing and fall prevention
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Monthly educational videos alone
Number of subjects: 1400
Study: 36207846

Group type: EXPERIMENTAL
Intervention: Dasatinib (Ph-D group)
Number of subjects: 7640

Group type: COMPARATOR
Intervention: Imatinib (Ph-I group)
Number of subjects: 7640

Group type: EXPERIMENTAL
Intervention: Vincristine plus dexamethasone (group A)
Number of subjects: 7640

Group type: COMPARATOR
Intervention: No additional treatment (group B)
Number of subjects: 7640

Group type: EXPERIMENTAL
Intervention: CCCG-ALL-2015 protocol
Number of subjects: 7640
Study: 33108582

Group type: COMPARATOR
Intervention: Incredible Years parenting intervention
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 387
Study: 32593173

Group type: EXPERIMENTAL
Intervention: 500 µg Nasacthin003 (nasal formulation with chitosan)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 250 µg IV Synacthen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: salivary cortisol and cortisone
Number of subjects: 60
Study: 35952956

Group type: EXPERIMENTAL
Intervention: Nonpneumatic compression device (NPCD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active pneumatic compression device (APCD)
Number of subjects: 50
Study: 34380842

Group type: EXPERIMENTAL
Intervention: Extra epidural anesthesia (GEA group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia and transversus abdominis plane block analgesia (TAP group)
Number of subjects: 60
Study: 33036670

Group type: EXPERIMENTAL
Intervention: Single-stent (SS) strategy
Number of subjects: 103

Group type: COMPARATOR
Intervention: Double-stent (DS) strategy
Number of subjects: 103
Study: 33567475

Group type: EXPERIMENTAL
Intervention: Active arm with rescue medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 35583186

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg (2.5 mg if impaired renal function or concomitant antiplatelet therapy)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard of care (vitamin K antagonist or antiplatelet therapy)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1500
Study: 34982433

Group type: EXPERIMENTAL
Intervention: Schroth exercises
Number of subjects: 34

Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation (PNF)
Number of subjects: 34
Study: 32698430

Group type: EXPERIMENTAL
Intervention: Technological treatment using SonicHand and Riablo™ systems providing auditory and visual biofeedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 34611057

Group type: EXPERIMENTAL
Intervention: High-Intensity Group (HIG)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Low-Intensity Group (LIG)
Number of subjects: 51
Study: 33557340

Group type: EXPERIMENTAL
Intervention: HPV-positive patients undergoing (chemo) radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: HPV-negative patients undergoing (chemo) radiotherapy
Number of subjects: 0
Study: 33807435

Group type: EXPERIMENTAL
Intervention: Technique-specific high-intensity interval training (HIIT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional taekwondo training
Number of subjects: 16
Study: 33059828

Group type: EXPERIMENTAL
Intervention: SAPIEN XT TAVR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SAPIEN 3 TAVR
Number of subjects: 0

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 0
Study: 35099994

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard prophylactic or intermediate-dose heparins
Number of subjects: 0
Study: 34203925

Group type: EXPERIMENTAL
Intervention: Fucoidan (3.0 g/day from beverages)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (citric acid, sucralose, and caramel beverages)
Number of subjects: 40
Study: 36170552

Group type: EXPERIMENTAL
Intervention: Weight stigma condition
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 49
Study: 33970254

Group type: EXPERIMENTAL
Intervention: Stepwise CMD prevention program, stage 1: CMD risk score completion.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stepwise CMD prevention program, stage 2: Additional measurements after increased risk identification.
Number of subjects: 0
Study: 35965109

Group type: EXPERIMENTAL
Intervention: 0.11 mg OC-02 SNS
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 0.55 mg OC-02 SNS
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 1.1 mg OC-02 SNS
Number of subjects: 165

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 165
Study: 33975710

Group type: EXPERIMENTAL
Intervention: Ultra-low dose imaging protocol (ULDP)
Number of subjects: 0
Study: 35716856

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups (CPAP and standard care)
Number of subjects: 83
Study: 32034019

Group type: EXPERIMENTAL
Intervention: Valacyclovir (dose-titrated from 2g to a targeted oral dose of 4g daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (lactose pills)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 130
Study: 35995640

Group type: EXPERIMENTAL
Intervention: Aromatherapy with 40% rose essential oil inhalation for three consecutive nights
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water inhalation as placebo
Number of subjects: 60
Study: 33399384

Group type: EXPERIMENTAL
Intervention: Lateral QLB
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Posterior QLB
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (no block)
Number of subjects: 96
Study: 32920321

Group type: EXPERIMENTAL
Intervention: Active cerebellar 1 Hz deep repetitive transcranial magnetic stimulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 34980596

Group type: EXPERIMENTAL
Intervention: P-DIPS intervention along with usual care
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 33378243

Group type: EXPERIMENTAL
Intervention: Consistent-mapping condition
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mixed group (both consistent and random conditions)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Random-mapping condition
Number of subjects: 72
Study: 32736891

Group type: EXPERIMENTAL
Intervention: Linagliptin 5mg added to background insulin therapy
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group continued insulin therapy
Number of subjects: 164
Study: 35344649

Group type: EXPERIMENTAL
Intervention: Ceritinib 450 mg with food
Number of subjects: 198

Group type: COMPARATOR
Intervention: Ceritinib 750 mg fasted
Number of subjects: 198
Study: 34644322

Group type: EXPERIMENTAL
Intervention: Cochlear Implant (CI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bone Conduction Device (BCD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Contralateral Routing of Sound hearing aids (CROS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: All treatment groups (CI, BCD, CROS)
Number of subjects: 120
Study: 32742646

Group type: EXPERIMENTAL
Intervention: Tapioca resistant maltodextrin (TRM) 50 g
Number of subjects: 16
Study: 34671998

Group type: EXPERIMENTAL
Intervention: Spiked-in estimator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Convex combination estimator
Number of subjects: 0
Study: 33573631

Group type: EXPERIMENTAL
Intervention: Online multimedia psychoeducational interventions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Telephone-based psychological counseling
Number of subjects: 50
Study: 33266447

Group type: COMPARATOR
Intervention: Fortified milk enriched with ω‐3 polyunsaturated fatty acids (EPA, DHA), vitamins (D, E, C, B6, B9, B12), and trace elements (zinc, selenium) consumed daily for 12 weeks.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fortified milk
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 48
Study: 35994324

Group type: EXPERIMENTAL
Intervention: Sociotechnical intervention with redesigned workflows and clinical decision support technology
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 369
Study: 34967847

Group type: EXPERIMENTAL
Intervention: sVLPD (very low-protein diet supplemented with ketoanalogues)
Number of subjects: 223

Group type: COMPARATOR
Intervention: LPD (standard low-protein diet)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: sVLPD
Number of subjects: 223

Group type: COMPARATOR
Intervention: LPD
Number of subjects: 223
Study: 32370806

Group type: EXPERIMENTAL
Intervention: Luseogliflozin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 24
Study: 34904798

Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard-care (salvage chemotherapy and autologous HSCT)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard-care
Number of subjects: 322
Study: 34099646

Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice daily)
Number of subjects: 30
Study: 32902389

Group type: EXPERIMENTAL
Intervention: Keenoa app (Keenoa-participant)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Keenoa app (Keenoa-dietitian)
Number of subjects: 102

Group type: COMPARATOR
Intervention: 3-day food diary (3DFD)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: System Usability Scale
Number of subjects: 102
Study: 34656144

Group type: EXPERIMENTAL
Intervention: High-dose PXT3003 (6/0.70/210 mg)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Low-dose PXT3003 (3/0.35/105 mg)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study: 35694969

Group type: EXPERIMENTAL
Intervention: ETMC5 (five-sensor esophageal thermal monitoring catheter)
Number of subjects: 106

Group type: COMPARATOR
Intervention: ETMC3 (three-sensor esophageal thermal monitoring catheter)
Number of subjects: 106
Study: 34351066

Group type: EXPERIMENTAL
Intervention: Interportal capsulotomy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Periportal capsulotomy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 33
Study: 32574167

Group type: EXPERIMENTAL
Intervention: Machine learning model using biosignals (electrocardiogram, electrodermal activity, respiration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bagged Trees classifier
Number of subjects: 0
Study: 34632854

Group type: EXPERIMENTAL
Intervention: Educational HPV intervention
Number of subjects: 20
Study: 32776199

Group type: EXPERIMENTAL
Intervention: Spherical coordinates as collective variables with enhanced sampling technique metadynamics
Number of subjects: 16
Study: 35814782

Group type: EXPERIMENTAL
Intervention: Morning LT4 intake (60 min before breakfast)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Bedtime LT4 intake (60 min after the last meal)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Both morning and bedtime LT4 intake
Number of subjects: 201
Study: 35124909

Group type: EXPERIMENTAL
Intervention: Intra-venous (IV) hydration with 0.9% Normal Saline before the procedure
Number of subjects: 42
Study: 34129159

Group type: EXPERIMENTAL
Intervention: Lactulose B (lactulose, n=24)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Lactulose A (placebo, n=22)
Number of subjects: 46
Study: 33351302

Group type: EXPERIMENTAL
Intervention: Yishen Tongluo Recipe combined with minimally invasive surgery (YTR+MIS)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Yishen Tongluo Recipe (YTR)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 116
Study: 34902474

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 87
Study: 33386751

Group type: EXPERIMENTAL
Intervention: Children living in areas with a larger number of churches at baseline
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Parents' involvement in school activities
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Low maternal education, poor parents' perception of oral health, non-use of dental services, low frequency of tooth brushing
Number of subjects: 639
Study: 33181830

Group type: EXPERIMENTAL
Intervention: Total carotenoid intake
Number of subjects: 2452

Group type: EXPERIMENTAL
Intervention: Lycopene intake
Number of subjects: 2452

Group type: EXPERIMENTAL
Intervention: Lutein + zeaxanthin intake
Number of subjects: 2452

Group type: EXPERIMENTAL
Intervention: Vitamin E intake
Number of subjects: 2452

Group type: EXPERIMENTAL
Intervention: Vitamin C intake
Number of subjects: 2452
Study: 35745229

Group type: EXPERIMENTAL
Intervention: Educational intervention with pre-discharge educational session and follow-up by telephone at 3, 6, and 12 months post-discharge
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control group (minimum intervention with educational leaflet, follow-up phone calls, and questionnaires)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 273
Study: 33692375

Group type: EXPERIMENTAL
Intervention: AAT M358R variant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AAT-RC (combination of CLEVE and PRSTE motifs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AAT-RC
Number of subjects: 0
Study: 32921396

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPVr)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (Artemether/lumefantrine)
Number of subjects: 40
Study: 35285357

Group type: EXPERIMENTAL
Intervention: Resource Facilitation (RF)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control (no Resource Facilitation)
Number of subjects: 211
Study: 34226094

Group type: EXPERIMENTAL
Intervention: Education plus planning condition (n=74 couples)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Education control (n=58 couples)
Number of subjects: 264
Study: 36182632

Group type: EXPERIMENTAL
Intervention: Munich Breathlessness Service (MBS)
Number of subjects: 183
Study: 34280999

Group type: EXPERIMENTAL
Intervention: Calm music group (CMG: n = 28)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Happy music group (HMG: n = 30)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sad music group (SMG: n = 27)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Calm music and happy music
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Negative mood states
Number of subjects: 85
Study: 34987791

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy using a harmonic scalpel (HS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Total thyroidectomy using conventional technique
Number of subjects: 100
Study: 32273252

Group type: EXPERIMENTAL
Intervention: DCMedsRec intervention by community pharmacists
Number of subjects: 977

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 977
Study: 33903855

Group type: EXPERIMENTAL
Intervention: Camostat mesilate 200 mg three times daily for 5 days
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Camostat mesilate
Number of subjects: 205
Study: 32338611

Group type: EXPERIMENTAL
Intervention: shield+curtain+drape group
Number of subjects: 614

Group type: COMPARATOR
Intervention: shield group
Number of subjects: 614

Group type: COMPARATOR
Intervention: shield+curtain group
Number of subjects: 614
Study: 36442895

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy
Number of subjects: 1523
Study: 34562501

Group type: EXPERIMENTAL
Intervention: Ozone treatment with no activation (NA)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ozone treatment with manual dynamic activation (MDA)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ozone treatment with passive ultrasonic activation (PUA)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ozone treatment with sonic activation (SA)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No ozone treatment (control)
Number of subjects: 108
Study: 33348794

Group type: EXPERIMENTAL
Intervention: Group physiotherapy activity and awareness intervention (PAAI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 101
Study: 35219302

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine 40 ml (medium concentration group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.4% ropivacaine 40 ml (low concentration group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.6% ropivacaine 40 ml (high concentration group)
Number of subjects: 90
Study: 33360219

Group type: EXPERIMENTAL
Intervention: Concentration camp/ghetto survivors
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Holocaust survivors not in concentration camps/ghettos
Number of subjects: 346

Group type: COMPARATOR
Intervention: Non-survivors
Number of subjects: 346
Study: 32636319

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35048610

Group type: EXPERIMENTAL
Intervention: Improved Unet network
Number of subjects: 117

Group type: COMPARATOR
Intervention: FCN‐8s network
Number of subjects: 117

Group type: COMPARATOR
Intervention: Unet network (Base)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Unet++ network
Number of subjects: 117
Study: 34730488

Group type: EXPERIMENTAL
Intervention: Limb remote ischemic preconditioning (RIPC)
Number of subjects: 50
Study: 32720906

Group type: EXPERIMENTAL
Intervention: Primeiros Laços home visiting intervention delivered by trained nurses, starting during the first 16 weeks of pregnancy until the child reaches 24 months of age.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Primeiros Laços home visiting intervention delivered by trained nurses.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 80
Study: 34937393

Group type: EXPERIMENTAL
Intervention: Device scenarios with 30-day mortality risks ranging from 0% to 15% and in-hospital complication risks ranging from 0% to 40%
Number of subjects: 613

Group type: COMPARATOR
Intervention: No-device scenario
Number of subjects: 613
Study: 34842534

Group type: EXPERIMENTAL
Intervention: Baby Steps Wellbeing
Number of subjects: 388

Group type: COMPARATOR
Intervention: Baby Care
Number of subjects: 388
Study: 34669239

Group type: EXPERIMENTAL
Intervention: Couplelinks online intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 75
Study: 32669232

Group type: EXPERIMENTAL
Intervention: Classical music (CM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Voice calling names (CN)
Number of subjects: 90
Study: 33432155

Group type: EXPERIMENTAL
Intervention: Reflective interview, observation of infant cues, and video interaction guidance (VIG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: VIG (for per-protocol analysis)
Number of subjects: 80
Study: 32289714

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS) at 1 mA for 22 and 24 minutes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS) at 1 mA for 26, 28, and 30 minutes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Assessment of short‐interval intracortical inhibition (SICI), intracortical facilitation (ICF), and long interval facilitation (LIF) via paired‐pulse TMS protocols
Number of subjects: 15
Study: 33231786

Group type: EXPERIMENTAL
Intervention: ICBIT (Internet-based guided self-help comprehensive behavioral intervention for tics)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list (WL) condition
Number of subjects: 41
Study: 36058230

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate 5 mg/day for 24 h plus standard care
Number of subjects: 325

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 325
Study: 33648350

Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg daily for 14 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dexamethasone 4 mg daily for 14 days
Number of subjects: 80
Study: 32074369

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Other Analgesics (OA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: No Analgesics (NA)
Number of subjects: 160
Study: 36084413

Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg or 75 mg per day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 33534804

Group type: EXPERIMENTAL
Intervention: Synthetic pheromone + insecticide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8
Study: 36273173

Group type: EXPERIMENTAL
Intervention: 24 mg encapsulated Xanthohumol (XN) per day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33757601

Group type: EXPERIMENTAL
Intervention: Priming to expect LED food by asking participants to choose a LED snack before the match.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not primed).
Number of subjects: 0